Skip to content
Home/Companies/MedTech/Sphere Bio (formerly Sphere Fluidics)
SB

Sphere Bio (formerly Sphere Fluidics)

MedTech·United Kingdom·Exited 2025·Held 4yr

Sphere Bio (formerly Sphere Fluidics) is a MedTech company, headquartered in United Kingdom.

Entry
2021
Hold
4yr
Exit
2025
Est. EV
–

Who owns Sphere Bio (formerly Sphere Fluidics)?

Sphere Bio (formerly Sphere Fluidics) was owned by Sofinnova Partners through Sofinnova Crossover Fund I (2018 vintage) from 2021 to 2025, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-06-11

Sofinnova Partners
Investor
Sofinnova Partners
Sofinnova Crossover Fund I · 2018 · VC

Key facts

HQUnited Kingdom
SectorMedTech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2025

More from Sofinnova Crossover Fund I

Other portfolio companies in the same fund.

GenSight Biologics
Active
BiotechFrance
Amolyt Pharma
Exited 2024
BiotechFrance· 2021
to
Artios Pharma
Active
BiotechUK· 2020
Calliditas
Exited 2024
BiotechSweden· 2020
to
Hemab Therapeutics
Active
BiotechDenmark· 2020
F2G
Active
BiotechUK· 2019

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Lattice Medical
Active
Finovam GestionFrance
QTAS
Active
OVNI CapitalGermany
Serres
Active
G Square Healthcare PEFinland· 2026
Stago
Active
ARCHIMEDFrance· 2026
Amoena
Active
Apera Asset ManagementGermany· 2025
Amotio
Active
Development Bank of WalesUK· 2025
Data refreshed weekly · Sourced from public filings